L-asparaginase-induced hypofibrinogenemia: A case report

O. Balaji; D. Amita; P. Navin

doi:10.22159/ajpcr.2017.v10i5.17320

L-asparaginase-induced hypofibrinogenemia: A case report

O. Balaji, D. Amita, P. Navin

Research output: Contribution to journal › Article › peer-review

Abstract

Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.

Original language	English
Pages (from-to)	11-12
Number of pages	2
Journal	Asian Journal of Pharmaceutical and Clinical Research
Volume	10
Issue number	5
DOIs	https://doi.org/10.22159/ajpcr.2017.v10i5.17320
Publication status	Published - 01-01-2017
Externally published	Yes

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmaceutical Science
Pharmacology (medical)

Access to Document

10.22159/ajpcr.2017.v10i5.17320

Cite this

@article{b3e44c6f54554fa8b066c1e4b59ba9e1,

title = "L-asparaginase-induced hypofibrinogenemia: A case report",

abstract = "Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.",

author = "O. Balaji and D. Amita and P. Navin",

year = "2017",

month = jan,

day = "1",

doi = "10.22159/ajpcr.2017.v10i5.17320",

language = "English",

volume = "10",

pages = "11--12",

journal = "Asian Journal of Pharmaceutical and Clinical Research",

issn = "0974-2441",

publisher = "Innovare Academics Sciences Pvt. Ltd",

number = "5",

}

TY - JOUR

T1 - L-asparaginase-induced hypofibrinogenemia

T2 - A case report

AU - Balaji, O.

AU - Amita, D.

AU - Navin, P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.

AB - Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.

UR - http://www.scopus.com/inward/record.url?scp=85018780782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018780782&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i5.17320

DO - 10.22159/ajpcr.2017.v10i5.17320

M3 - Article

AN - SCOPUS:85018780782

SN - 0974-2441

VL - 10

SP - 11

EP - 12

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

IS - 5

ER -

L-asparaginase-induced hypofibrinogenemia: A case report

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this